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Objective To compare thediagnostic performance of 2 height-independent equations used to calculate estimated
glomerular filtration rate (eGFR), those of Pottel (eGFR-Pottel) and the British Columbia Children’s Hospital (BCCH)
(eGFR-BCCH), with the commonly used Schwartz equation (eGFR-Schwartz).
Study designWe externally validated eGFR-Pottel and eGFR-BCCH in a well-characterized pediatric patient pop-
ulation (n=152) andcompared their diagnostic performancewith that of eGFR-Schwartz usingBland-Altmananalysis.
All patients underwent glomerular filtration ratemeasurement using the gold standard single-injection inulin clearance
method (GFR-inulin).
ResultsMedianGFR-inulinwas92.0mL/min/1.73m2 (IQR, 76.1-107.4mL/min/1.73m2).ComparedwithGFR-inulin,
themean bias for eGFR-Schwartzwas10.1mL/min/1.73m2 (95% limits of agreement [LOA],77.5 to 57.2mL/min/
1.73m2), comparedwith12.3mL/min/1.73m2 (95%LOA,72.6 to47.9mL/min/1.73m2) for eGFR-Pottel and22.1
mL/min/1.73 m2 (95% LOA, 105.0 to 60.8 mL/min/1.73 m2) for eGFR-BCCH. eGFR-Pottel showed comparable
accuracy to eGFR-Schwartz, with 77% and 76% of estimates within 30% of GFR-inulin, respectively. eGFR-BCCH
was less accurate than eGFR-Schwartz (66% of estimates within 30% of GFR-inulin; P < .01).
Conclusion The performance of eGFR-Pottel is superior to that of eGFR-BCCH and comparable with that
of eGFR-Schwartz. eGFR-Pottel is a valid alternative to eGFR-Schwartz in children and could be reported by the
laboratory if height data are not available. (J Pediatr 2013;163:1722-7).
G
lomerular filtration rate (GFR) is the best indicator of renal function in children.1 Gold standard GFR measure-
ment techniques2 are cumbersome, costly, and often unavailable. As an alternative, current guidelines recommend
the use of estimated GFR (eGFR) based on serum creatinine concentration in both adults and children.3 The most
commonly used equation for calculating eGFR in children is the Schwartz equation (eGFR-Schwartz),4 which is calculated
from serum creatinine concentration, height, and an empirical constant, k, that adjusts for muscle mass and the creatinine
measurement method. A major disadvantage of eGFR-Schwartz is the need for height information, which hampers its use
in settings in which height data are not available. This precludes automatic reporting of eGFR in children by most clinical
laboratories, which has become common practice in adult patients, because most equations for adults do not require
anthropometric data.5,6 To overcome this problem, Zappittelli et al7 and Pottel et al8 recently developed eGFR equations
(termed the modified British Columbia Children’s Hospital [BCCH] equation [eGFR-BCCH] and eGFR-Pottel, respec-
tively) using different approaches to estimate GFR in children independent of height. In their hands, both equations per-
formed similarly to eGFR-Schwartz. Because a height-independent eGFR can be easily calculated by laboratory reporting
software, use of these alternative equations may significantly improve pediatric care and facilitate screening for chronic
kidney disease (CKD) in children. eGFR-BCCH and eGFR-Pottel have not yet been validated using inulin clearance, how-
ever.
In the present study, we aimed to externally validate both the eGFR-BCCH and eGFR-Pottel equations using measure-
ment of GFR by the single-injection inulin clearance method (GFR-inulin) as the gold standard in a well-defined
pediatric cohort with varying degrees of CKD. We also compared the diagnostic performance of theFrom the Departments of 1Pediatric Nephrology,
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BCCH British Columbia Children’s Hospital
CKD Chronic kidney disease
eGFR Estimated glomerular filtration rate
eGFR-BCCH Estimated glomerular filtration rate according to the British Columbia Children’s
Hospital equation
eGFR-Pottel Estimated glomerular filtration rate according to the Pottel equation
eGFR-Schwartz Estimated glomerular filtration rate according to the Schwartz equation
GFR Glomerular filtration rate
GFR-inulin Glomerular filtration rate measured by the single-injection inulin clearance
method
IDMS Isotope dilution mass spectrometry
LOA Limits of agreement
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We hypothesized that both equations would perform as
well as eGFR-Schwartz.Methods
Data from all patients who consecutively underwent a
gold standard GFR measurement at the Pediatric Renal
Center of the VU University Medical Center between
March 2008 and September 2012 were analyzed retrospec-
tively. GFR measurements were performed based on clin-
ical indication. Anthropometric data were obtained by
chart review. All patient data were recorded in an anon-
ymous manner such that subjects could not be identified
directly or through identifiers linked to the subjects. The
study was therefore exempted from institutional review
board review. Anthropometric data values are expressed
as SDSs (z-scores) away from the mean using the growth
data of the Fourth Dutch Growth Study.9 The reference
standard and the index test were performed at the same
time. Because muscle mass influences serum creatinine
levels and thus the performance of creatinine-based equa-
tions, malnourished patients (ie, children with a body
mass index SDS <3) and patients with spina bifida
were excluded from this study.
GFR was measured by single-injection inulin clearance, a
validated method for accurately determining GFR in chil-
dren.10 TheGFR-inulin studieswere performedat the pediatric
outpatient clinic after an overnight fast. Clinical hydration sta-
tus of all patients was assessed beforemeasurement. Before and
during GFR measurement, patients had free access to water or
tea without sugar. GFR measurements were performed exclu-
sively in patients with normal hydration status as assessed by
the supervising physician. All patients received a single intrave-
nous dose (5000 mg per 1.73 m2 of body surface area, with a
maximum dose of 5000 mg) of inulin (Inutest; Fresenius,
Bad Homburg, Germany) administered over 1 minute. Dedi-
cated nurses assessed for extravasation of inulin during admin-
istration.
Serial blood samples were obtained at 10, 30, 90, and 240
minutes after injection. After sampling, blood was centri-
fuged for 5minutes at 1800 g and then stored at20C un-
til measurements. Inulin was measured within 14 days using
an enzymatic method based on the determination of fructose
concentration after acid hydrolysis of inulin, as described by
Jung et al11 with minor modifications.12 GFR-inulin was
calculated using a 2-compartmental model with MW/Pharm
3.5 software (Mediware, Groningen, The Netherlands), a
pharmacokinetic program using Bayesian estimates from pa-
tient and population data.10
Immediately before the GFR-inulin clearance study,
blood was drawn for measurement of serum creatinine,
using an enzymatic method (Modular Analytics <P>;
Roche Diagnostics, Mannheim, Germany), which is trace-
able to an isotope dilution mass spectrometry (IDMS)
standard.13eGFR Equations
All 3 equations are based on IDMS-traceable standards for
creatinine measurement. eGFR-Schwartz is calculated as:
eGFR-Schwartz

mL=min1:73 m2

¼ 41:3 heightðmÞ
serum creatinine ðmg=dLÞ
eGFR-BCCH, by Zappittelli et al,7 estimates GFR based on
serum creatinine concentration and age:
inverse lnðeGFR BCCHÞðmL=min=1:73 m2Þ
¼ 8:067þ ð1:034 lnð0:011=ðserum creatinineðmg=dLÞÞÞ
þð0:305 lnðageðyearsÞÞÞÞ þ 0:064 if male:
eGFR-Pottel uses median serum creatinine reference
values:
eGFRPottelmL=min=1:73 m2
¼ 107:3

serum creatinine ðmg=dLÞ
Q

where Q is the median serum creatinine concentration for
children based on age and sex (Table I).14
Renal function was classified according to the National
Kidney Foundation’s Kidney Disease Outcome Quality
Initiative guidelines for CKD.3 Underclassification was
considered if the CKD stage based on GFR-inulin was higher
than that based on eGFR, and overclassification was consid-
ered if the CKD stage based on GFR-inulin was lower than
that based on eGFR.Statistical Analyses
All analyses were performed using SPSS 20.0 (IBM,
Armonk, New York). Continuous variables are presented
as mean (SD) for variables with a Gaussian distribution
and as median (IQR) for variables with a non-Gaussian dis-
tribution. Differences between continuous variables be-
tween patients aged #14 years and those aged >14 years
were analyzed using the Student t test. Nonnormally distrib-
uted variables were naturally log-transformed before anal-
ysis. Differences in bias between the tested equations were
analyzed using the paired-samples t test. Qualitative vari-
ables are shown as counts (proportion) and were compared
using the c2 test or McNemar test. The analytical perfor-
mance of the different eGFR equations was assessed in
compliance with the Standard for the Reporting of Diag-
nostic Accuracy studies criteria.15 Using Bland-Altman
analysis,16 we calculated bias (ie, mean difference between
GFR-inulin and eGFR) and the limits of agreement (LOA;
mean bias  1.96  SD). Accuracy was determined as the
proportions of patients with an eGFR value within 30%,
20%, and 10% of that measured by GFR-inulin. Differences
were considered statistically significant at a P value <.05 and
a trend of P values of .05-.10 in all analyses.1723
Table I. Median serum creatinine concentrations for
different age categories14
Age All patients Males Females
Newborn 0.54 - -
1 mo to <1 y 0.25 - -
1 to <2 y 0.27 - -
2 to <3 y 0.30 - -
3 to <4 y 0.33 - -
4 to <5 y 0.36 - -
5 to <6 y 0.38 - -
6 to <7 y 0.43 - -
7 to <8 y 0.45 - -
8 to <9 y 0.47 - -
9 to <10 y 0.50 - -
10 to <11 y 0.52 - -
11 to <12 y 0.54 - -
12 to <13 y 0.57 - -
13 to <14.5 y 0.61 - -
14.5 to <15.5 y - 0.68 0.62
15.5 to <16.5 y - 0.78 0.68
16.5 to <17.5 y - 0.82 0.70
17.5 to <18.5 y - 0.85 0.71
18.5 to <19.5 y - 0.86 0.71
19.5 to <20.5 y - 0.88 0.70
Median serum creatinine concentrations for children and adolescents (median serum creatinine
= 0.0270 age + 0.2329).14 To express serum creatinine concentration in mmol/L, multiply by
88.4.
THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 163, No. 6Results
A total of 152 participants were included in the analyses; their
characteristics are summarized in Table II. Because eGFR-
Pottel was calibrated in a cohort of children aged 2-14
years, children aged >14 years are displayed separately.
Ninety-five children (63%) had a congenital anomaly of
the kidney or urinary tract, 26 (18%) had glomerular
disease, and 29 (19%) had a malignancy. Two children
(1%) were healthy siblings. The median age at testing was
14.5 years (IQR, 9.3-17.5 years). The median GFR-inulin
value was 92.0 mL/min/1.73 m2 (IQR, 76.1-107.4 mL/min/
1.73 m2; range, 19.4 and 173.8 mL/min/1.73 m2). The
GFR-inulin value was <90 mL/min/1.73 m2 (indicatingTable II. Clinical characteristics of participants at renal func
Characteristic Total (n = 15
Age, y, median (IQR) 14.5 (9.3-17.5
Male sex, % 60
Height SDS, mean (SD) 0.5 (1.2)
Weight SDS, mean (SD) 0.2 (1.3)
Body mass index SDS, mean (SD) 0.2 (1.3)
Malignancy, % 19
Renal function parameters
Serum creatinine, mg/dL, median (IQR) 0.71 (0.50-0.9
GFR-inulin, mL/min/1.73 m2, median (IQR) 92.0 (76.1-10
eGFR-Schwartz, mL/min/1.73 m2, median (IQR) 91.0 (76.6-11
eGFR-Pottel, mL/min/1.73 m2, median (IQR) 96.3 (80.4-11
eGFR-BCCH, mL/min/1.73 m2, median (IQR) 98.7 (82.7-12
CKD stage 1, %* 51
CKD stage 2, %* 38
CKD stage 3-5, %* 11
Data for patients aged $14 years are displayed separately.
*CKD stages based on GFR-inulin: stage 1, >90 mL/min/1.73 m2; stage 2, 60-89 mL/min/1.73 m2;
1724CKD stage 2 or worse) in 49% of measurements. The rate
of a GFR-inulin value <90 mL/min/1.73 m2 tended to be
higher in children aged >14 years compared with children
aged #14 years (55% vs 42%; P = .10). Differences in
median GFR between age groups were not identified by
GFR-inulin or eGFR-Pottel, whereas children aged >14
years had lower median eGFR-Schwartz and eGFR-BCCH
values than those aged #14 years (P < .001 for both
equations).
The Figure shows Bland-Altman plots for all tested
equations. The mean difference between GFR-inulin and
eGFR-Schwartz was 10.1 mL/min/1.73 m2 (SD, 34.3 mL/
min/1.73 m2; 95% LOA, 77.5 to 57.2 mL/min/1.73 m2),
and the mean difference between GFR-inulin and eGFR-
Pottel was 12.3 mL/min/1.73 m2 (SD, 30.7 mL/min/1.73
m2; 95% LOA, 72.6 to 47.9 mL/min/1.73 m2) (P = .01,
eGFR-Pottel vs eGFR-Schwartz). eGFR-BCCH showed the
highest bias, at 22.1 mL/min/1.73 m2 (SD, 42.3 mL/min/
1.73 m2; 95% LOA, 105.0 to 60.8 mL/min/1.73 m2; P <
.001, eGFR-BCCH vs eGFR-Schwartz) (Table III). For
eGFR-Schwartz and eGFR-BCCH, but not for eGFR-Pottel,
overestimation of GFR-inulin was significantly higher in
children aged #14 years compared with those aged >14
years (P < .001 for both tested equations).
The accuracy of the tested equations, measured as the per-
centage of estimates within 10%, 20%, and 30% of GFR-
inulin values, is shown in Table III. Accuracy was comparable
in eGFR-Pottel and eGFR-Schwartz; however, eGFR-BCCH
demonstrated significantly lower proportions of estimates
within 20% and 30% of GFR-inulin values compared with
eGFR-Schwartz (P = .001 and .002, respectively). A
subanalysis of children aged >14 years showed higher
accuracy within 30% of GFR-inulin values for all estimating
equations, which was most marked in eGFR-Schwartz and
eGFR-BCCH (Table III).
CKD stages according to Kidney Disease Outcome Quality
Initiative guidelines are displayed in Table IV. The
misclassification rate was lower for eGFR-Pottel (37%)
compared with eGFR-BCCH and eGFR-Schwartz (bothtion measurement
2) £14 y (n = 74) >14 y (n = 78)
) 9.2 (6.0-11.4) 17.4 (16.4-18.0)
60 60
0.6 (1.3) 0.4 (1.1)
0.3 (1.2) 0.0 (1.5)
0.3 (1.2) 0.1 (1.3)
35 4
3) 0.52 (0.38-0.65) 0.89 (0.76-0.98)
7.4) 95.1 (76.8-113.1) 90.0 (76.1-99.8)
4.5) 101.9 (88.3-131.0) 81.0 (71.7-92.7)
2.0) 98.5 (83.4-123.3) 94.9 (77.6-107.0)
9.4) 123.6 (98.0-151.1) 88.7 (76.0-99.0)
58 45
28 46
14 9
stage 3-5, <60 mL/min/1.73 m2.
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Figure. Bland-Altman plots for A, eGFR-Schwartz, B, eGFR-Pottel, and C, eGFR-BCCH showing bias (solid line) and the 95%
LOA (ie, mean bias  1.96  SD [gray area]).
December 2013 ORIGINAL ARTICLES40%). Underestimation of CKD stage was least frequent with
eGFR-Schwartz (20%) compared eGFR-Pottel (25%; P= .06)
and eGFR-BCCH (28%; P < .001). The proportion of
patients with a GFR-inulin value <75 mL/min/1.73 m2 (ie,
cutoff value for progressed CKD) but an eGFR >75
mL/min/1.73 m2 was 9% for eGFR-Schwartz, 10% for
eGFR-Pottel, and 11% for eGFR-BCCH. When an eGFR
cutoff value of <60 mL/min/1.73 m2 for eGFR was used,
the proportion of patients with a GFR-inulin value >60
mL/min/1.73 m2 was 3% for eGFR-Schwartz, 1% for
eGFR-Pottel, and 1% for eGFR-BCCH.
Discussion
In our hands, the height-independent eGFR equation of Pot-
tel et al8 demonstrated similar diagnostic performance as theHeight-Independent Estimation of Glomerular Filtration Rate in Cwidely used eGFR-Schwartz equation. eGFR-BCCH,
however, was less precise and had lower accuracy than
eGFR-Schwartz and eGFR-Pottel. Based on these findings,
we recommend the use of eGFR-Pottel over eGFR-BCCH
in children when height data are unavailable.
Height-independent equations are important because they
can be used for the automatic reporting of eGFR by labora-
tories, which often do not have access to anthropometric
data. From a broader perspective, height-independent
eGFR can facilitate screening for pediatric CKD.17 Bearing
in mind the well-documented imprecision of estimating
equations, a finding of impaired GFR should be confirmed
using a gold standard GFR measurement.18
Originating from muscle metabolism, creatinine produc-
tion is closely related to muscle mass. In children, muscle
mass increases with linear growth, along with a parallelhildren: An Alternative to the Schwartz Equation 1725
Table III. Diagnostic performance of eGFR equations
Mean bias,
mL/min/
1.73 m2
Accuracy
within 30%,
%
Accuracy
within 20%,
%
Accuracy
within 10%,
%
eGFR-
Schwartz
10.1 76 61 28
#14 yrs 22.2 68 58 31
>14 yrs 1.3 85 63 24
eGFR-Pottel 12.3* 77 63 34
#14 yrs 14.8 77 62 37
>14 yrs 10.0 77 63 32
eGFR-BCCH 22.1† 66* 47* 28
#14 yrs 39.7 50 28 18
>14 yrs 5.3 81 64 39
Shown are mean differences between GFR-inulin and the 3 eGFR estimates (mL/min/1.73 m2)
and proportion of eGFR estimates within the 30% limits of GFR-inulin. Subanalyses based on
age <14 y and #14 y are also presented.
*P = .01 compared with eGFR-Schwartz.
†P < .001 compared with eGFR-Schwartz.
THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 163, No. 6increase in serum creatinine reference values. This prompted
Schwartz et al19 and Counahan et al20 to develop equations
combining height and serum creatinine to estimate GFR.
The use of different k values allows correction for differences
in muscle mass and the specificity of the creatinine assay
used.21 Until recently, large interlaboratory differences in
creatinine measurement precluded the widespread use of
differentiated pediatric reference values. This has changed
since the implementation of IDMS-traceable creatinine mea-
surements in clinical chemistry.
Instead of using height as a surrogate for age-specific creat-
inine production, Pottel et al8 used age-specific IDMS-trace-
able creatinine concentrations in healthy children. Our
results show that this method has similar performance as
eGFR-Schwartz.
The maximum accuracy within 20% of GFR-inulin values
for our tested eGFR measures was 63%, for eGFR-Pottel,
which might not be ideal for clinical practice. Nevertheless,
the accuracies within 30% of GFR-inulin for eGFR-Schwartz
(76%) and eGFR-Pottel (77%) were comparable with the
accuracy originally reported by Schwartz et al19 (79%).
Thus, we believe that the use of eGFR-Pottel instead of
eGFR-Schwartz in clinical practice is justified. Still, equa-
tions based on serum cystatin C level alone or cystatin C
in combination with serum creatinine levels have been
shown to be superior in children,22 particularly in children
with abnormal muscle mass, such as those with spina bifida
or malnourishment, who were excluded from our study. In
contrast to creatinine, cystatin C is produced at a constant
rate in children and adults and is independent of muscleTable IV. CKD stage based on Kidney Disease Outcome Qua
CKD stage 1, % CKD stage 2, % CKD stage 3-5, % U
eGFR-Schwartz 51 38 11
eGFR-Pottel 61 31 9
eGFR-BCCH 64 26 10
CKD stages: stage 1, >90 mL/min/1.73 m2; stage 2, 60-89 mL/min/1.73 m2; stage 3-5, <60 mL/m
*Based on GFR-inulin.
1726mass; thus, many serum cystatin C–based equations do
not require height information.23 However, given the lack
of a certified calibrator for cystatin C until recently,24 the
nonuniformity in cystatin C measurement techniques has
hindered the universal use of cystatin C as a marker for renal
function.
We decided to test the eGFR-BCCH of Zappitelli et al,7 a
modification of the equation originally published by Matt-
man et al,25 because it was established using an IDMS-
traceable creatinine assay. eGFR-BCCH overestimated GFR
compared with eGFR-Pottel and eGFR-Schwartz. This over-
estimation might be explained by differences in the gold
standard technique used for calibration. Zappitelli et al7
used the continuous iothalamate plasma infusion technique,
whereas Pottel et al8 used single-injection 51Cr-EDTA clear-
ance and Schwartz et al19 used single-injection iohexol clear-
ance. It has been shown that the continuous iothalamate
plasma infusion technique can overestimate GFR when the
duration of sampling is too short,26 which might explain
why eGFR-BCCH overestimated GFR compared with
eGFR-Pottel and eGFR-Schwartz in the present study.
Along with differences in the gold standard measurement
technique used, GFR values also depend on the population
tested.27 Differences in diet or obesity rates, both of which
can affect renal function, might have further influenced
the performance of eGFR-BCCH in this study. Furthermore,
the fact that mean GFR in our cohort (88 mL/min/1.73 m2)
more closely resembles the mean GFR in the original calibra-
tion population of Pottel et al (84 mL/min/1.73 m2) than
that of Zappitelli et al (77 mL/min/1.73 m2) may have
favored eGFR-Pottel over eGFR-BCCH. The superior per-
formance of eGFR-Schwartz in our subjects aged >14 years
is in line with previous findings28 and likely reflects the
lower GFR in the subgroup of patients aged >14 years. In
line with our findings in the younger age group, De Souza
et al29 have suggested that a lower k value of 36.8 rather
than 41.3 (for creatinine in mg/dL and height in m) might
be more suitable for children aged <13 years. Recalibration
of the Schwartz equation was beyond the scope of the pre-
sent study, however.
Our study has several limitations. First, although we used
the inulin single-injection method, which has been shown to
accurately determine true GFR in children and adults,10,30 we
measured inulin by an enzymatic method, which has a lower
sensitivity than mass spectrometry measurement and can be
biased by cross-reactions with other serum metabolites, such
as glucose. To reduce this risk, all GFR measurements werelity Initiative guidelines for eGFR equations
nderclassification of CKD stage, %* Overclassification of CKD stage, %*
20 20
25 12
28 30
in/1.73 m2.
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December 2013 ORIGINAL ARTICLESperformed after an overnight fast. Single-injection GFR mea-
surements are hampered by the need for complete equilibra-
tion of the tracer in the extracellular space after injection,
which must be separated from the decline in concentration
reflecting glomerular filtration. This problem is seen primar-
ily at low GFR, where late sampling is essential. Nonetheless,
our results for both eGFR-Pottel and eGFR-Schwartz are
comparable with the original reports.
Second, the original studies differed in the age spectrum of
the respective calibration populations. eGFR-BCCHwas cali-
brated in a cohort aged 2-18 years, eGFR-Schwartz was cali-
brated in a cohort aged 1-16 years, and eGFR-Pottel was
calibrated in children aged#14 years. In line with this differ-
ence in age among the calibration populations, GFR-Schwartz
and eGFR-BCCH performed significantly better in adoles-
cents, but eGFR-Pottel did not. Finally, we did not recalibrate
the eGFR equations to our local creatinine assay, because the
assay was IDMS-traceable, as was the case in the original re-
ports. Recalibration might have corrected for differences in
patient population and the gold standard GFR measurement
and thus possibly improved the performance of the equations.
However, our study aimed to evaluate diagnostic perfor-
mance of the original equations in clinical practice, rather
than establish yet another equation for estimating GFR.
In summary, our findings from the present study show
that the performance of the height-independent eGFR-Pottel
was comparable with that of eGFR-Schwartz and superior to
that of eGFR-BCCH in a large pediatric cohort. Our study
supports use of the eGFR-Pottel by pediatricians and clinical
laboratories to automatically report eGFR when anthropo-
metric data are unavailable. n
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